VSI/St. Jude
This article was originally published in The Gray Sheet
Executive Summary
Patent litigation settlement agreement announced July 12 calls for Vascular Solutions, Inc. to pay St. Jude 2.5% royalty on sales of its Duett femoral artery closure device in exchange for a non-exclusive license to St. Jude's "Fowler" patents related to sealing devices. The pact also provides for a non-exclusive cross license to VSI's "Gershony" patents if needed by St. Jude, which markets the Angio-Seal femoral artery closure device